Interphase cytogenetic (in situ hybridization) analysis of astrocytomas using archival, formalin-fixed, paraffin-embedded tissue and nonfluorescent light microscopy

American Journal of Clinical Pathology

Volumn 108, Issue 2, 1997, Pages 166-174

  Perry, Arie ^a   Tonk, Vijay ^a,b   McIntire, D D ^a   White III, Charles L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytoma; Chromosome aberrations; In situ hybridization; Interphase; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; CANCER SURVIVAL; CARCINOGENESIS; CHROMOSOME 10; CHROMOSOME 7; CLINICAL ARTICLE; CYTOGENETICS; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE MICROSCOPY; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; IN SITU HYBRIDIZATION; INTERPHASE; MALE; MONOSOMY; PRIORITY JOURNAL; TRISOMY;

EID: 0030750249     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/108.2.166     Document Type: Article

References (54)

1. Ganju V, Jenkins RB, O'Fallon JR, et al. Prognostic factors in gliomas: a multivariate analysis of clinical, pathologic, flow cytometric, and molecular markers. Cancer. 1994;74:920-927.
2. Kimmel DW, O'Fallon JR, Scheithauer BW, et al. Prognostic value of cytogenetic analysis in human cerebral astrocytomas. Ann Neurol. 1992;31:534-542.
3. Ransom DT, Ritland SR, Moertel CA, et al. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosomes Cancer. 1992;5:357-374.
4. Bigner SH, Mark J, Bigner DD. Cytogenetics of human brain tumors. Cancer Genet Cytogenet. 1990;47:141-154.
5. Jenkins RB, Kimmel DW, Moertel CA, et al. A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet. 1989;39:253-279.
6. Bigner SH, Mark J, Burger PC, et al. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res. 1988;88:405-411.
7. Rey JA, Bello MJ, de Campos JM, Kusak ME, Ramos C, Benitez J. Chromosomal patterns in human malignant astrocytomas. Cancer Genet Cytogenet. 1987;29:201-221.
8. von Deimling A, Louis DA, Wiestler OD. Molecular pathways in the formation of gliomas. Glia. 1995;15:328-338.
9. Collins VP. Genetic alterations in gliomas. J Neurooncol. 1995;24:37-38.
10. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumors. Brain Pathol. 1993;3:255-268.
11. Ye Z, Wu JK, Darras BT. Loss of heterozygosity for alleles on chromosome 10 in human brain tumors. Neurol Res. 1993;15:59-62.
12. Rasheed BKA, Fuller GN, Friedman AH, Bigner DD, Bigner SH. Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes Cancer. 1992;5:75-82.
13. Van de Keift E, De Boulle K, Willems P, et al. Loss of constitutional heterozygosity in human astrocytomas. Acta Neurochir (Wien). 1992;117:172-177.
14. Wu JK, Darras BT. Loss of heterozygosity on the short arm of chromosome 17 in human astrocytomas. Neurol Res. 1992;14:39-44.
15. Olopade OI, Jenkins RB, Ransom DT, et al. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res. 1992;52:2523-2529.
16. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res. 1992;52:674-679.
17. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer. 1988;62:2152-2165.
18. Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System. Berlin, Germany: Springer-Verlag; 1993.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
20. Cox DR. Regression models and life-tables. J R Stat Soc (B). 1972;34:187-220.
21. SAS Institute Inc. SAS/STAT User's Guide, Version 6. Cary, NC: SAS Institute; 1990.
22. Schlegel J, Scherthan H, Arens N, Stumm G, Kiessling M. Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization. J Neuropathol Exp Neurol. 1996;55:81-67.
23. Feuerstein BG, Mohapatra G. Molecular cytogenetic quantitation of gains and losses of genetic material from human gliomas. J Neurooncol. 1995;24:47-55.
24. Kim DH, Mohapatra G, Bollen A, Waldman FM, Feuerstein BG. Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer. 1995;60:812-819.
25. Mohapatra G, Kim DH, Feuerstein BG. Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes Chromosomes Cancer. 1995;13:86-93.
26. Schrock E, Thiel G, Lozanova T, et al. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol. 1994;144:1203-1218.
27. Dalrymple SJ, Herath JF, Ritland SR, Moertel CA, Jenkins RB. Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomas. J Neurosurg. 1995;83:316-323.
28. Dreyling MH, Bohlander SK, Adeyanju MO, Olopade OI. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res. 1995;55:984-988.
29. Kwak T, Nishizaki T, Nakayama H, et al. Detection of structural aberrations of chromosome 17 in malignant gliomas by fluorescence in situ hybridization (FISH). Acta Oncol. 1995;34:27-30.
30. Paulus W, Bayas A, Ott G, Roggendorf W. Interphase cytogenetics of glioblastoma and gliosarcoma. Acta Neuropathol. 1994;88:420-425.
31. Vagner-Capodano AM, Zattara-Cannoni H, Gamarelli D, et al. Detection of i(17q) chromosome by fluorescent in situ hybridization (FISH) with interphase nuclei in medulloblastoma. Cancer Genet Cytogenet. 1994;78:1-6.
32. Arnoldus EPJ, Wolters LBT, Voormolen JHC, et al. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors. J Neurosurg. 1992;76:997-1003.
33. Arnoldus EPJ, Noordermeer IA, Peters ACB, et al. Interphase cytogenetics of brain tumors. Genes Chromosomes Cancer. 1991;3:101-107.
34. Dhingra K, Sahin A, Supak J, et al. Chromosome in situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: technical considerations and biological implications. Breast Cancer Res Treat. 1992;23:201-210.
35. Hopman AHN, Moesker O, Smeets AWGB, et al. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res. 1991;51:644-651.
36. Emmerich P, Jauch A, Hofmann MC, Cremer T, Walt H. Interphase cytogenetics in paraffin-embedded sections from human testicular germ cell tumor xenografts and in corresponding cultured cells. Lab Invest. 1989;61:235-242.
37. Hopman AHN, Ramaekers FCS, Raap AK, et al. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry. 1988;89:307-316.
38. Arnoldus EPJ, Peters ACB, Bots GTAM, Raap AK, van der Ploeg M. Somatic pairing of chromosome 1 centromeres in interphase nuclei of human cerebellum. Hum Genet. 1989;83:231-234.
39. Dalrymple SJ, Herath JF, Borell TJ, Moertel CA, Jenkins RB. Correlation of cytogenetic and fluorescence in situ hybridization (FISH) studies in normal and gliotic brain. J Neuropathol Exp Neurol. 1994;53:448-456.
40. Arnoldus EPJ, Noordermeer IA, Peters AC, Raap AK, Van der Ploeg M. Interphase cytogenetics reveals somatic pairing of chromosome 17 centromeres in normal human brain tissue, but no trisomy 7 or sex-chromosome loss. Cytogenet Cell Genet. 1991;56:214-216.
41. Burger PC, Green SB. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer. 1987;59:1617-1625.
42. Cohadon F, Aouad N, Rougier A, et al. Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors. J Neurooncol. 1985;3:105-111.
43. Nelson DF, Nelson JS, Davis DR, et al. Survival and prognosis of patients with astrocytoma with atypical or anaplastic features. J Neurooncol. 1985;3:99-103.
44. Kim TS, Halliday AL, Hedley-Whyte ET, Convery K. Correlates of survival and the Daumas-Duport grading system for astrocytomas. J Neurosurg. 1991;74:27-37.
45. Hurtt MR, Moossy J, Donovan-Peluso M, Locker J. Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol. 1992;51:84-90.
46. Berrozpe G, Miro R, Caballin MR, Salvador J, Epozcue J. Trisomy 7 may be a primary change in noninvasive transitional cell carcinomas of the bladder. Cancer Genet Cytogenet. 1990;50:9-14.
47. Emanuel A, Szucs S, Weier HU, Kovacs G. Clonal aberrations of chromosomes X, Y, 7, and 10 in normal kidney tissue of patients with renal cell tumors. Genes Chromosomes Cancer. 1992;4:75-77.
48. Voravud N, Shin DM, Ro JY, et al. Increased polysemies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res. 1993;53:2874-2883.
49. van Dekken H, Kerstens HM, Tersteeg TA, Verhofstad AA, Vooijs GP. Histological preservation after in situ hybridization to archival solid tumor sections allows discrimination of cells bearing numerical chromosome changes. J Pathol. 1992;168:317-324.
50. Hermann ME, Lalley PA. Significance of trisomy 7 in thyroid tumors. Cancer Genet Cytogenet. 1992;62:144-149.
51. Mark J, Dahlenfors R, Havel G, Bockmann P. Benign parotid oncocytoma with the chromosomal abnormality trisomy 7. Anticancer Res. 1991;11:1735-1737.
52. Bardi G, Johansson B, Pandis N, et al. Trisomy 7 in short-term cultures of colorectal adenocarcinomas. Genes Chromosomes Cancer. 1991;3:149-152.
53. Heim S, Mandahl N, Jin Y, et al. Trisomy 7 and sex chromosome loss in human brain tissue. Cytogenet Cell Genet. 1989;52:136-138.
54. Lindstrom E, Salford LG, Sverre H, et al. Trisomy 7 and sex chromosome loss need not be representative of tumor parenchyma cells in malignant glioma. Genes Chromosomes Cancer. 1991;3:474-479.